European consensus statement on phenotypes of pustular psoriasis.

about

The Genetic Basis of Psoriasis.Clinical and Genetic Heterogeneity of Mutations in Psoriatic Skin Disease A small population, randomised, placebo-controlled trial to determine the efficacy of anakinra in the treatment of pustular psoriasis: study protocol for the APRICOT trial

P2860

Q52765463-ED7B56D8-3A64-404F-B49A-DB2A23191F48 Q58553821-0FAC3418-3373-4683-B2E2-88B21F48E7A4 Q58695016-F3154369-51B4-4C36-958A-9BC235A6DC69

P2860

European consensus statement on phenotypes of pustular psoriasis.

Item

http://www.wikidata.org/entity/Q39353851

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

European consensus statement on phenotypes of pustular psoriasis.

@en

European consensus statement on phenotypes of pustular psoriasis.

@nl

type

Item

label

European consensus statement on phenotypes of pustular psoriasis.

@en

European consensus statement on phenotypes of pustular psoriasis.

@nl

prefLabel

European consensus statement on phenotypes of pustular psoriasis.

@en

European consensus statement on phenotypes of pustular psoriasis.

@nl

P1476

European consensus statement on phenotypes of pustular psoriasis.

@en

P2093

A A Navarini

http://www.w3.org/2001/XMLSchema#string

A D Burden

http://www.w3.org/2001/XMLSchema#string

C Smith

http://www.w3.org/2001/XMLSchema#string

ERASPEN Network

http://www.w3.org/2001/XMLSchema#string

K Kingo

http://www.w3.org/2001/XMLSchema#string

U Mrowietz

http://www.w3.org/2001/XMLSchema#string

P2860

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

AP1S3 mutations are associated with pustular psoriasis and impaired Toll-like receptor 3 trafficking

Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis.

William John Munro and Munro's abscess, and Franz Kogoj and Kogoj's spongiform pustule.

Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis.

Management of palmoplantar pustulosis: do we need to change?

Bimodal immune activation in psoriasis.

The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants.

Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis.

Down's syndrome and acute leukemia: myeloblastic or lymphoblastic? Report of forty-three cases and review of the literature.

P304

1792-1799

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JDV.14386

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28585342

http://www.w3.org/2001/XMLSchema#string

European consensus statement on phenotypes of pustular psoriasis.

about

P2860

P2860

European consensus statement on phenotypes of pustular psoriasis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698